financetom
Business
financetom
/
Business
/
Japan's Honda to start selling micro-sized electric vans in October
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Japan's Honda to start selling micro-sized electric vans in October
Jun 12, 2024 7:29 PM

TOKYO (Reuters) - Honda Motor ( HMC ) will start selling a micro-sized electric van targeted at Japan's delivery industry in October, the Japanese automaker said on Thursday, joining an increasingly crowded part of the market.

The small electric commercial van will have a cruising range of 245 km (152 miles), the company said in a statement. It will be classed as a "kei" vehicle, which are low-powered, low-taxed domestic vehicles.

The launch of the new model comes as Japan's second-biggest automaker by volume separately plans to start selling an electric kei passenger car next year.

Honda ( HMC ) is a powerhouse in Japan's substantial market of kei micro-sized cars. Its N-Box model has long topped the ranks of Japan's kei passenger vehicle market.

Micro kei vehicles are hugely popular among businesses and households to deliver agriculture produce, parcels and other goods in urban areas and the countryside in Japan, in part due to their relatively cheap price.

The roll-out comes months after Toyota Motor delayed the launch of a small electric van that it is developing with Suzuki Motor and Daihatsu, following a safety test scandal at Daihatsu.

Mitsubishi Motors Corp in December 2023 relaunched its own small commercial van, Minicab EV.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Australia's Telix Pharma says FDA seeks more data on cancer diagnostic drug; shares plunge
Australia's Telix Pharma says FDA seeks more data on cancer diagnostic drug; shares plunge
Aug 28, 2025
Aug 28 (Reuters) - The U.S. Food and Drug Administration (FDA) sought more data from Telix Pharmaceuticals ( TLX ) on its drug to detect a form of kidney cancer, the Australian cancer diagnostics firm said on Thursday. Telix's Sydney-listed shares plunged as much as 24%, its worst intraday fall on record. It ended 18.8% lower at A$14.95 and was...
Berkshire raises stake in Japan's Mitsubishi above 10%
Berkshire raises stake in Japan's Mitsubishi above 10%
Aug 28, 2025
TOKYO, Aug 28 (Reuters) - Berkshire Hathaway ( BRK/A ), through its wholly-owned unit National Indemnity Company, has raised its stake in Japan's Mitsubishi Corp ( MSBHF ) and Mitsui & Co ( MITSF ) , the companies said on Thursday. Berkshire raised its stake in Mitsubishi ( MSBHF ) to 10.23% from 9.74% previously, the company said in a...
Cel-Sci Prices $10 Million Stock Offering
Cel-Sci Prices $10 Million Stock Offering
Aug 28, 2025
03:22 AM EDT, 08/28/2025 (MT Newswires) -- Cel-Sci ( CVM ) said late Wednesday it priced a public offering of about 1.1 million common shares at $9 per share for expected gross proceeds of about $10 million. Net proceeds will be used for the company's drug development program, working capital and general corporate purposes, it said. Closing of the offering...
Why Is CEL-SCI Stock Crashing After-Hours?
Why Is CEL-SCI Stock Crashing After-Hours?
Aug 28, 2025
CEL-SCI Corporation ( CVM ) shares tumbled 38.19% in after-hours trading to $8.06 on Tuesday following the cancer immunotherapy company’s announcement of a $10 million public offering priced below current market levels. Check out the current price of CVM stock here.  Offering Details Drive Share Price Volatility The clinical-stage company priced 1,111,200 common shares at $9.00 each, representing a 30.9%...
Copyright 2023-2026 - www.financetom.com All Rights Reserved